Rethinking Lyme Disease Testing: A New Approach to Early Detection
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Emerging Tests-dtet
Diagnostics Pipeline: FDA Approves Visby Medical’s Over-The-Counter Women’s Sexual Health Test
It’s the first PCR-based sexually transmitted infection test platform for at-home use
Diagnostics Pipeline: Savara Introduces Blood Test to Detect aPAP, a Rare Lung Disorder
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies
From - Diagnostic Testing & Emerging Technologies
Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last…
Donor-Derived, Cell-Free DNA May Predict Lung Transplant Rejection
From - Diagnostic Testing & Emerging Technologies
Elevated donor-derived, cell-free DNA (ddcfDNA) in the 3 months post-lung transplant can identify clinically silent allograft injury and…
Calprotectin May Predict Arthritis Relapse
...
Already a member? Log in here
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
From - Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…
Diagnostics Sector Saw Increased Investment, Exits in 2018
From - Diagnostic Testing & Emerging Technologies
Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment…
Sequencing Shows Promise in Care of Common Kidney Disease
...
Already a member? Log in here
Cytokines Could Predict Risk of Side Effects From Immunotherapy
From - Diagnostic Testing & Emerging Technologies
Blood-based cytokine markers may help identify cancer patients at greatest risk of developing side effects from immunotherapy treatment, according to…
Polygenic Risk Score Predicts Drug Efficacy with Schizophrenia
...
Already a member? Log in here
Panel Size Affects Accuracy of Tumor Mutational Burden Calculation
From - Diagnostic Testing & Emerging Technologies
It has the makings of a Hollywood movie. Three recent college grads start a medical testing software company that uses a digital pathology platform, meet with success, and…
Sequencing-Based Panel May Improve Evaluation of Thyroid Nodules
From - Diagnostic Testing & Emerging Technologies
A genetic test panel can help patients avoid unnecessary diagnostic thyroid surgeries, according to a study published Nov. 8 in…
